• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eli Lilly Covid Antibody Trial Paused Due to Safety Concerns

sharon sanders

sharon sanders

Editor-in-Chief & President
Eli Lilly Covid Antibody Trial Paused Due to Safety Concerns

By
Riley GriffinOctober 13, 2020, 2:44 PM EDT Updated on October 13, 2020, 5:43 PM EDT



Eli Lilly & Co. said enrollment of participants in a clinical trial of its antibody treatment for Covid-19 has been paused due to a potential safety concern, pushing down the company’s shares.

An independent data safety monitoring board recommended pausing enrollment in the U.S. government-sponsored trial, a company spokeswoman said in a statement. Lilly didn’t provide information about what caused the panel to recommend the pause.


more..

https://www.bloomberg.com/news/artic...afety-concerns


-------------------------------------

Eli Lilly’s phase three trial of its ACTIV-3 monoclonal antibody treatment for the coronavirus has been paused due to potential safety concerns.

https://www.cnbc.com/2020/10/13/us-...-antibody-treatment-over-safety-concerns.html
 
You must log in or register to reply here.
Back
Top Bottom